Customizing Myopia Control With Multifocal Toric Contact Lens

NCT04352868 — Not applicable, Withdrawn, University of Alabama at Birmingham

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT04352868
StatusWithdrawn - COVID-19
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: quadruple, treatment
SponsorUniversity of Alabama at Birmingham (Other)
ConditionsRefractive Errors, Myopia
InterventionsIntelliwave multifocal, toric, soft contact lens, Intelliwave toric, soft contact lens (Device)
Datesstart 2020-09-01 (estimated), primary completion 2021-09-01 (estimated), completion 2022-09-01 (estimated), first posted 2020-04-20, last updated 2020-11-09

Related Papers Related Patents Related Grants Related Experts
All trials for Refractive Errors All trials for Myopia All trials of Intelliwave multifocal, toric, soft contact lens All trials of Intelliwave toric, soft contact lens

-Summary

This study will evaluate the ability of toric multifocal contact lens to reduce the change of myopia progression in children (aged 8-12) with myopic astigmatism.

Expand all sections  ·  Collapse all

+Detailed description

The purpose of this study is to assess if a center distance toric multifocal contact lenses can slow the amount of change of myopia progression in children with myopia plus astigmatism. Multifocal contact lenses have been theorized to influence the peripheral optics of the eye such that they slow the rate of myopia progression in nearsighted children. This outcome is yet to be evaluated in children with myopia plus astigmatism.The secondary outcome is to measure the change in peripheral optics caused by the contact lens. This information is key to understanding the mechanism of multifocal contact lens optics on the eye. Ultimately this information would be used to create a software that can estimate the effect of multifocal contact lenses on the peripheral optics of the child's eye. This software can potentially be used by practitioners worldwide to better customize multifocal contact lenses to slow myopia progression.

+Arms and interventions

ArmTypeInterventionsDescription
Toric soft contact lensActive comparatorDevice: Intelliwave toric, soft contact lensToric soft contact lens
Multifocal toric soft contact lensExperimentalDevice: Intelliwave multifocal, toric, soft contact lensA multifocal toric soft contact lens with a +2.00 D add.
  • Intelliwave multifocal, toric, soft contact lens (Device): This is a quarterly disposable, multifocal, toric soft contact lens commercially available from Art Optical Contact Lens, Inc.
  • Intelliwave toric, soft contact lens (Device): This is a quarterly disposable toric soft contact lens commercially available from Art Optical Contact Lens, Inc.

+Outcome measures

Primary outcomes

  • Refractive error progression [1 years]: Refractive error measured by cycloplegic autorefraction in both eyes, will be measured at baseline and at one year to assess the difference in spherical component of the refractive error between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)
  • Axial length [1 years]: Change in axial length as measured by non-contact axial length both eyes, will be measured at baseline and at one year to assess the difference in change in axial length between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)

+Eligibility

Sex: All, ages: 8 Years to 12 Years

Inclusion Criteria:

* 8 to 12 years, inclusive, at baseline examination
* -0.50 to -6.00 D, inclusive, spherical component, cycloplegic autorefraction
* ≥0.75 DC, cycloplegic autorefraction
* 0.1 logMAR or better best-corrected visual acuity in each eye

Exclusion Criteria:

* Eye disease or refractive error conditions (e.g., keratoconus, retinal abnormalities, retinopathy of prematurity, etc.)
* Ocular surgery, severe ocular trauma, active ocular infection or inflammation
* Subjects with a condition or in a situation, which in the examiner's opinion, may put the subject at significant risk, may confound the study results, or may significantly interfere with their participation in the study.

+Investigators